Professional development

Outside the Lab Personalized medicine

"Sexy" Needs Substance

| Rajesh Rao

We need to explain the context when using “grab bag” phrases in science and medicine

Outside the Lab Animal models

Pulling Back the Pre-Clinical Curtain

| William Aryitey

Are mouse models the best option we have?

Outside the Lab Public health

Change is Here, But Are We Ready For it?

| Giorgio Stanta

Patient-centric healthcare can only be fully achieved if we change the current organizational methods
Outside the Lab Public health

Accessing Big Pharma's Conscience

| Jayasree K. Iyer

Jayasree K. Iyer, Executive Director of Access to Medicine Foundation, the Netherlands
Outside the Lab Professional development

Speed Versus Safety for Cell Therapy

| Karen Nichols and Jacques Galipeau

We want faster translation of cell therapies, but is it worth sacrificing public trust?
Outside the Lab Drug discovery

Taking Cues from the City of Notions

| Chas Bountra

Boston leads the drug discovery field, and the UK could soon follow suit
Research Field Professional development

The Synthesizer

| Jef Boeke

Jef Boeke, Professor, Department of Biochemistry and Molecular Pharmacology at NYU
Outside the Lab Professional development

Diversity, Equity, and Problem-solving

| Kimberly Tanner

Diversity and equity in the biosciences are about more than just "being nice"
Outside the Lab Clinical trials

See-Through Science at GSK

| Murray Stewart

Opening up our clinical trial results takes investment, but it's the right thing to do
Outside the Lab Biomedical engineering

The Organ Grower

| Charlotte Barker

Anthony Atala, Director, Wake Forest Institute for Regenerative Medicine
Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist